A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186

Summary

This study will assess the safety, tolerability, and pharmacokinetics of AZD0186 following single ascending doses (SAD) via oral administration in healthy adult participants.

Timeline

Start

2022-12-20

Primary completion

2023-05-10

Completion

2023-05-10

Outcome

Outcome not reported

Stopped: “The decision was based on the overall data profile obtained from this study which did not demonstrate sufficient differentiation to surpass the current standard of care.”

Drugs

Indications